SPARK Advisory Partners is pleased to announce that it has advised TyraTech, Inc. (AIM: TYR and TYRU) on its Placing and Subscription to raise £1.87 million. TyraTech, Inc., a natural life sciences company focusing on nature-derived insect and parasite control products, announces that it has conditionally raised £1.87 million before expenses by means of a placing and subscription of new shares in the capital of the Company. The funds raised will be used primarily to assist the successful launch of the Vamousse™ head lice product range in Walmart and other major US retailers.
https://www.sparkadvisorypartners.com/images/spark-AP-logo.png 0 0 developer https://www.sparkadvisorypartners.com/images/spark-AP-logo.png developer2014-01-24 14:23:562016-05-06 10:08:29SPARK acts for TyraTech, Inc in relation to its Placing and Subscription of new Common shares
Offices in London and Leeds
We are based in the City of London but also have an office in Leeds which makes it easy for us to provide our services wherever you may be. We offer our services to clients anywhere in the United Kingdom, plus we also have many clients overseas. In addition to our London based clients, our team has recently dealt with clients in Leeds, Manchester, Sheffield, Birmingham, Nottingham, Bristol, Glasgow, Edinburgh plus many other UK cities.
- SPARK appointed Financial and Nominated Adviser to Equatorial Palm Oil plc26th June 2020 - 5:12 pm
- SPARK appointed as Nominated Adviser to Redx Pharma plc20th May 2020 - 3:15 pm
- SPARK acts as Sponsor to Cathay International Holdings Limited24th April 2020 - 4:59 pm
- Funding solutions in Covid-19 market conditions20th April 2020 - 5:00 pm